3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Neoplasm Metastasis
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Sarcoma
1
Refractory Solid Tumors
1
Carcinoma, Transitional Cell
1
Interventions
selinexor
1
pembrolizumab
1
pazopanib
1
Proton Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Doxorubicin
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
eribulin
×
30 days
×
Clear all
No trials found.